公司资料
SIGA Technologies Inc 股价、新闻与催化剂
- 股票代码:
- SIGA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
3.35 USD (-1.47%)
收盘价
最后更新: 2026年10月1日
310M USD
市值
股价为何变动
截至 2026年10月1日，SIGA 下跌 1.47%，收于 $3.35。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
SIGA Technologies is a specialty pharmaceutical company best known for its antiviral countermeasure portfolio, especially against orthopox and smallpox-related threats. Its story is tied to government procurement and biodefense demand.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, SIGA sits in specialty pharmaceuticals and biodefense.
商业模式特征
The company depends on government contracts, product supply, and the economics of public-health preparedness rather than broad commercial volume.
生物医药行业定位
SIGA is a niche biodefense name whose stock is driven by contract timing and preparedness spending.
未来催化剂
- SIGA Technologies’ catalysts are TPOXX procurement, biodefense contract cadence, and any government-demand update tied to smallpox preparedness. This is a contract-driven story, so procurement timing matters more than clinical readouts.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。